×
ADVERTISEMENT

isatuximab

Compared With Standard Multiple Myeloma Therapy, Isatuximab Doubles Odds of MRD Negativity

In transplant-eligible patients with newly diagnosed multiple myeloma (MM), the novel anti-CD38 monoclonal antibody ...

FEBRUARY 23, 2024

Load more